Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results

BACKGROUND: This study investigated the effect of oral dimercapto succinic acid (DMSA) therapy for children with autism spectrum disorders ages 3-8 years. METHODS: Phase 1 involved 65 children who received one round of DMSA (3 days). Participants who had high urinary excretion of toxic metals were s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Adams, James B, Baral, Matthew, Geis, Elizabeth, Mitchell, Jessica, Ingram, Julie, Hensley, Andrea, Zappia, Irene, Newmark, Sanford, Gehn, Eva, Rubin, Robert A, Mitchell, Ken, Bradstreet, Jeff, El-Dahr, Jane
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2774660/
https://ncbi.nlm.nih.gov/pubmed/19852789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-9-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados